Anzeige
Meldung des Tages: Diese Zahlen lügen nicht: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Inovio Pharma. News

Aktie
WKN:  A400EJ ISIN:  US45773H4092 US-Symbol:  INO Branche:  Biotechnologie Land:  USA
1,20 $
+0,04 $
+3,45%
1,0201 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
70,23 Mio. €
Streubesitz
61,67%
KGV
-0,75
Index-Zuordnung
-

Inovio Pharmaceuticals News

21.10.25 - PR Newswire
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
Clinical Proof-​of-Concept Data for DNA-​Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine PR Newswire
02.10.25 - PR Newswire
INOVIO Reports Inducement Grant Under Inducement Plan
INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire
25.09.25 - PR Newswire
INOVIO to Participate in Upcoming Scientific Conferences
INOVIO to Participate in Upcoming Scientific Conferences PR Newswire
26.08.25 - PR Newswire
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults PR Newswire
25.08.25 - PR Newswire
INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire
14.08.25 - PR Newswire
Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment
Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment PR Newswire
12.08.25 - PR Newswire
INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights PR Newswire
11.08.25 - PR Newswire
Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)
Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP) PR Newswire
04.08.25 - PR Newswire
INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025
INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025 PR Newswire
07.07.25 - PR Newswire
INOVIO to Present at Upcoming Scientific Conference
INOVIO to Present at Upcoming Scientific Conference PR Newswire
03.07.25 - PR Newswire
INOVIO Announces Pricing of $25 Million Public Offering
INOVIO Announces Pricing of $25 Million Public Offering PR Newswire
02.07.25 - PR Newswire
INOVIO Announces Proposed Public Offering
INOVIO Announces Proposed Public Offering PR Newswire
13.05.25 - PR Newswire
INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights
INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights PR Newswire
30.04.25 - PR Newswire
INOVIO to Present at Upcoming Scientific and Investor Conferences
INOVIO to Present at Upcoming Scientific and Investor Conferences PR Newswire
29.04.25 - PR Newswire
INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »